Oxicodona/Naloxona Stada (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Naloxone Hydrochloride, the active ingredient in Oxicodona/Naloxona Stada, is a combination opioid analgesic and opioid antagonist presented as a fixed‑dose oral formulation for systemic use. It is employed in the management of moderate to severe pain while reducing the risk of opioid‑induced respiratory depression. GNH USA supplies Oxicodona/Naloxona Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxicodona/Naloxona Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxicodona/Naloxona Stada is used in the context of opioid‑based pain management where respiratory safety is a concern. - Moderate to severe acute pain: provides effective analgesia while mitigating opioid‑induced respiratory depression. - Post‑operative pain: facilitates postoperative pain control with a built‑in safety mechanism. - Cancer‑related pain: offers strong pain relief for cancer patients with reduced risk of overdose. - Chronic non‑cancer pain: assists in long‑term pain management where opioid therapy is indicated. - Break‑through pain episodes: delivers rapid relief for breakthrough pain while limiting respiratory side effects.

Side effects are reported from both components of the combination and may vary in frequency.

Common Side Effects: - Nausea and vomiting - Constipation - Dizziness - Drowsiness - Headache - Dry mouth

Serious or Rare Side Effects: - Respiratory depression (if naloxone effect is insufficient) - Severe hypotension - Hepatic impaired un un ... ... ... ...  ...  a  

t   t """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""